Indaptus Therapeutics, Inc. (INDP) Financials
INDP Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 14.9 million | 2.8 million |
2023-09-30 | 17.8 million | 2.5 million |
2023-06-30 | 20.8 million | 2.2 million |
2023-03-31 | 23.1 million | 2.0 million |
INDP Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -2.6 million | 745525 |
2023-09-30 | -3.7 million | 764803 |
2023-06-30 | -2.1 million | 728466 |
2023-03-31 | -5.0 million | 727144 |
INDP Net Income
No data available :(
INDP Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 13.4 million | - | 175053 |
2023-09-30 | 16.0 million | - | 196241 |
2023-06-30 | 19.7 million | - | 216591 |
2023-03-31 | 21.7 million | - | 236506 |
INDP Shares Outstanding
INDP Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 2.0 million | 2.1 million | - |
2023-09-30 | - | 2.2 million | 2.0 million | - |
2023-06-30 | - | 1.5 million | 2.0 million | - |
2023-03-31 | - | 1.9 million | 2.6 million | - |
INDP Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 320 |
2023-09-30 | - | 321 |
2023-06-30 | - | 322 |
2023-03-31 | - | 321 |
INDP
Price: $2.03
52 week price:
Earnings Per Share: -1.83 USD
P/E Ratio: -0.91
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 19752
Market Capitalization: 23.7 million